Haloperidol-induced catalepsy is absent in dopamine D 2 , but maintained in dopamine D 3 receptor knock-out mice

By Boulay D.   Depoortere R.   Oblin A.   Sanger D.J.   Schoemaker H.   Perrault G.  

European Journal of Pharmacology, Vol. 391, Iss. 1, 2000-03 ,pp. : 63-73

Elsevier

Access to resources Recommend Favorite

Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor

By Wood M.D.   Boyfield I.   Nash D.J.   Jewitt F.R.   Avenell K.Y.   Riley G.J.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Enhanced striatal dopamine D 2 receptor-induced [ 35 S]GTP S binding after haloperidol treatment

By Geurts M.   Hermans E.   Maloteaux J.-M.  

European Journal of Pharmacology, Vol. 382, Iss. 2, 1999-10 ,pp. : 119-127

Elsevier

Access to resources Recommend Favorite

The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors

By Wicke K.   Garcia-Ladona J.  

European Journal of Pharmacology, Vol. 424, Iss. 2, 2001-07 ,pp. : 85-90

Elsevier

Access to resources Recommend Favorite

The dopamine D₁ receptor agonist and D₂ receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats

By Milivojevič Nataša   Krisch Igor   Sket Dušan   Živin Marko  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 6, 2004-06 ,pp. : 576-582

Springer Publishing Company

Access to resources Recommend Favorite